Related Experiment Video
Updated: May 26, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The pathology and clinical features of early recurrent membranous glomerulonephritis
E F Rodriguez1, F G Cosio, S H Nasr
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Abstract:
We assessed the earliest manifestations of recurrent membranous glomerulonephritis (MGN) in renal allografts. Clinical, laboratory and pathologic data were reviewed in 21 patients at the initial biopsy within 4 months post-transplant with evidence of MGN and on follow-up biopsies, compared to a biopsy control group of eight transplants without recurrent MGN. The mean time of first biopsy with pathologic changes was 2.7 months. In each earliest biopsy, immunofluorescence (IF) showed granular glomerular basement membrane (GBM) staining for C4d, IgG, kappa and lambda. IF for C3 was negative or showed trace staining in 16/21. On each MGN biopsy positive by IF, 14/19 showed absence of deposits or rare tiny subepithelial deposits by electron microscopy (EM). At the earliest biopsy, the mean proteinuria was 1.1 g/day; 16 patients had <1 g/day proteinuria. Follow-up was available in all patients (mean 35 months posttransplant). A total of 13 patients developed >1 g/day proteinuria; 12 were treated with: rituximab (n = 8), ACEI and increased prednisone dose (n = 2), ACEI or ARB only (n = 2). All patients showed reduction in proteinuria after treatment. A total of 11/16 patients showed progression of disease by EM on follow-up biopsy. Recognition of early allograft biopsy features aids in diagnosis of recurrent MGN before patients develop significant proteinuria.
Insights
Early diagnosis of recurrent membranous glomerulonephritis (MGN) in kidney transplants is possible through identifying specific biopsy findings. Recognizing these early signs aids timely intervention, preventing significant proteinuria.
Area of Science:
- Nephrology
- Transplant Immunology
- Pathology
Background:
- Recurrent membranous glomerulonephritis (MGN) is a significant complication after kidney transplantation.
- Early detection of recurrent MGN is crucial for effective management and graft survival.
Purpose of the Study:
- To identify the earliest pathological and clinical manifestations of recurrent MGN in renal allografts.
- To establish diagnostic criteria for early-stage recurrent MGN in transplant recipients.
Main Methods:
- Retrospective review of clinical, laboratory, and pathological data from 21 patients with early recurrent MGN and 8 controls.
- Analysis of initial and follow-up renal allograft biopsies using immunofluorescence (IF) and electron microscopy (EM).
Main Results:
- Earliest biopsies (mean 2.7 months post-transplant) showed granular GBM staining for C4d, IgG, kappa, and lambda by IF, with minimal or absent subepithelial deposits on EM.
- Most patients (16/21) had proteinuria <1 g/day at initial biopsy.
- 11/16 patients showed disease progression on follow-up EM, and 13 patients developed significant proteinuria (>1 g/day).
Conclusions:
- Specific IF and EM findings in early allograft biopsies can diagnose recurrent MGN before significant proteinuria develops.
- Early recognition facilitates prompt treatment, leading to proteinuria reduction.
- Identifying early features of recurrent MGN improves diagnostic accuracy and patient outcomes.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Encephalitis ll: Pathophysiology
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Pyelonephritis I: Introduction
Acute Kidney Injury II: Pathophysiology
